KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 76 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $101,115 | +7.0% | 10,500 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $94,500 | -41.4% | 10,500 | -48.8% | 0.00% | -50.0% |
| Q1 2023 | $161,130 | -65.1% | 20,500 | -66.1% | 0.00% | -63.6% |
| Q1 2020 | $462,000 | -57.1% | 60,400 | 0.0% | 0.01% | -21.4% |
| Q4 2019 | $1,076,000 | -37.3% | 60,400 | +0.7% | 0.01% | -33.3% |
| Q1 2019 | $1,717,000 | +44.9% | 60,000 | 0.0% | 0.02% | +31.2% |
| Q4 2018 | $1,185,000 | +30.7% | 60,000 | +46.3% | 0.02% | +77.8% |
| Q3 2018 | $907,000 | +172.4% | 41,000 | 0.0% | 0.01% | +200.0% |
| Q2 2018 | $333,000 | -14.4% | 41,000 | 0.0% | 0.00% | -25.0% |
| Q1 2018 | $389,000 | – | 41,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 422,310 | $10,849,000 | 5.86% |
| COMMODORE CAPITAL LP | 214,467 | $5,510,000 | 2.20% |
| Vivo Capital, LLC | 1,863,296 | $47,868,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 214,533 | $5,486,000 | 1.45% |
| Nicholas Investment Partners, LP | 594,130 | $15,263,000 | 1.06% |
| Altium Capital Management LP | 128,130 | $3,292,000 | 0.91% |
| Affinity Asset Advisors, LLC | 100,000 | $2,569,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $1,285,000 | 0.70% |
| APIS CAPITAL ADVISORS, LLC | 30,000 | $771,000 | 0.70% |
| Birchview Capital, LP | 40,000 | $1,028,000 | 0.61% |